$DXYZNeutralMed

How to Own SpaceX Without Buying the IPO

SpaceX filed an S-1 with the SEC on May 20, 2026 for a Nasdaq IPO, targeting a valuation of $1.75T–$2T and about 5% of the company in float. The filing shows 2025 revenue of $18B, with Starlink at $11.4B (61%); Starlink reported 10.3M paid subscriptions in Q1 2026 and connectivity income of $4.42B. The article highlights ETF exposure via XOVR and a closed-end fund (DXYZ), and also points to Rocket Lab’s Neutron contract and backlog.

8/10
6/10
Med
Neutral
today/this week as SpaceX IPO filing and RKLB contract details circulate
SpaceX IPO excitement is risk-on for space proxies; RKLB’s contract is a fundamental offset to sentiment-only exposure

DXYZ is a high-beta proxy to SpaceX IPO sentiment, but premium-to-NAV risk is central to the trade.

The article reports DXYZ surged over 21% to near its 52-week high as SpaceX IPO excitement intensified, and notes it trades at large NAV premiums historically.

If SpaceX IPO headlines cool, DXYZ’s premium could compress, creating downside even without changes to underlying holdings.

Background

SpaceX filed an S-1 for a Nasdaq IPO; the article frames how to gain exposure without buying the IPO directly.

Why it matters

The text provides concrete exposure vehicles (XOVR, DXYZ) and a separate fundamental catalyst for RKLB via a large launch contract and backlog update.

Market relevance

Traders can use RKLB’s contract/backlog as a fundamental catalyst, while XOVR/DXYZ act as sentiment proxies with structural frictions (SPV marking, premium-to-NAV).

Market effects

Space/launch equities may see relative inflows as investors seek liquid proxies to SpaceX’s IPO narrative; contract visibility (backlog) becomes a key differentiator.

Primarily US-listed growth/space names; sentiment spillover could affect US-listed satellite/launch supply-chain names.

SpaceX IPO attention can re-rate global space infrastructure demand expectations, but this article’s actionable catalysts are US-listed vehicles and RKLB.

Alternative perspectives

SpaceX IPO excitement may already be priced into space proxies; DXYZ’s premium-to-NAV and XOVR’s SPV/marking frictions can cause underperformance even if SpaceX headlines remain strong.

RKLB’s Neutron execution risk (historical delays) and the possibility that the “confidential customer” contract terms or milestones could shift; for XOVR/DXYZ, valuation update frequency and liquidity can dominate returns.

Key entities

  • SpaceX

    Filed an S-1 for a Nasdaq listing; Starlink is described as the majority of revenue and the only profitable segment.

  • XOVR

    ERShares Private-Public Crossover ETF holding SpaceX exposure via an SPV.

  • DXYZ

    Destiny Tech100 holding stakes including SpaceX; described as trading at premiums to NAV.

  • RKLB

    Rocket Lab; described as signing its largest launch contract and targeting first Neutron launch in Q4 2026.

Related articles

$RKLBMed

How to Own SpaceX Without Buying the IPO

SpaceX filed an S-1 with the SEC on May 20, 2026, targeting a Nasdaq listing. The filing showed 2025 revenue of $18B, with Starlink at $11.4B (61% of total). Starlink reported 10.3M paid subscriptions in Q1 2026, up from a year earlier, and connectivity generated $4.42B in income. The IPO is expected to float ~5% at a $1.75T–$2T valuation; the article highlights ETF exposure via XOVR and alternative public exposure via Rocket Lab, citing a May 2026 Neutron/Electron launch contract and $2.2B back

$RKLBLow

Should You Buy RocketLab Stock Instead of SpaceX at IPO?

The article discusses rising investor interest in space-related stocks, highlighting Rocket Lab (RKLB) shares up 4.61% as of June 2, 2026 afternoon prices. It frames the question of whether Rocket Lab stock should be considered instead of SpaceX around its IPO, but provides no additional financial figures or company-specific details.

$RKLBMed

Space nerds, rejoice! SpaceX’s IPO lifts dreams of the cosmos.

SpaceX’s upcoming IPO has drawn major attention from space enthusiasts and investors. The company set an IPO price of $135 per share, valuing it at about $1.77 trillion, according to the report. RocketLab and Intuitive Machines shares have risen as the deal nears, and analysts said a successful IPO could boost broader space-industry investment.

$RKLBMed

Jamie Dimon Pitches SpaceX IPO To 2,500 Wealthy Clients As Space Stocks (NASDAQ: RKLB), (NASDAQ: LUNR), (NASDAQ: FLY), (NASDAQ: SIDU) Recover

Space stocks rebounded after a Wednesday selloff tied to concerns about SpaceX’s valuation ahead of its June 12 Nasdaq debut. Bloomberg reported JPMorgan CEO Jamie Dimon will pitch the SpaceX IPO to 2,500 wealthy clients with SpaceX executives. SpaceX set a $135/share price, targeting a $75B raise and >$1.8T valuation; up to 30% may go to individuals. Rocket Lab, Intuitive Machines, and Sidus rose ~1%; Firefly gained 0.5%.